The diagnostic value of interleukin-6 in distinguishing tuberculous pleurisy from malign effusion Source: Eur Respir J 2001; 18: Suppl. 33, 499s Year: 2001
Diagnostic contribution of PICADAR score in etiological evaluation of patients with bronchiectasis of unknown etiology Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018
Is there any clinical application for determining the serum cytokines profile in sarcoid patients? Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008
The value of adenosin-deaminase in etiologic diagnosis of pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 167s Year: 2002
Induced sputum TNF-α level as possible prognostic factor in sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 115s Year: 2007
Validation of an etiological diagnostic model in adults with a diagnosis of bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
Differential diagnostic efficiency of T cells subsets versus interferon-gamma, tumor necrosis factor alpha and adenosine deaminase in distinguishing tuberculous from malignant pleural effusions Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
The importance of inflammatory markers in sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Reumathoid factor: diagnostic utility in pleural fluid Source: Eur Respir J 2003; 22: Suppl. 45, 191s Year: 2003
Discordant exudates and their impact on Light’s criteria accuracy to diagnose exudate effusions. The value of clinical presentation Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015
Diagnostic value of procalcitonin, CRP, leukocytes and BAL neutrophils for pulmonary complications in the immunocompromised host Source: Eur Respir Rev 2006; 15: 228-229 Year: 2006
Diagnostic value of procalcitonin, CRP, leukocytes and BAL neutrophils for pulmonary complications in the immunocompromised host Source: Eur Respir J 2006; 28: Suppl. 50, 806s Year: 2006
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of infection with mycobacterium tuberculosis Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008
General features in tuberculous pleurisy cases and contribution of diagnostic methods to diagnosis Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008
Evaluation of the utility of using pleural fluid cholesterol as a new criterion for the differential diagnosis between transudates and exudates Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011
Is pleural VEGF a useful parameter? Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease Source: International Congress 2017 – Update on TB: latest news Year: 2017
Diagnostic and prognostic value of an undifferentiated connective tissue disease index in idiopathic interstitial pneumonia Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009
Value of induced sputum in the etiologic diagnosis of chronic cough Source: Eur Respir J 2002; 20: Suppl. 38, 449s Year: 2002